Categories Earnings, Health Care
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth quarter of 2023.
- Fourth-quarter revenues increased 9% annually to $901.6 million; organic revenue growth was 8%
- Net income attributable to shareholders moved up to $194.52 million from $172.2 million a year earlier
- On a per-share basis, fourth-quarter earnings rose to $2.32 per share from $2.05 per share in Q4 2022
- For fiscal 2024, the management expects revenues to be in the range of $3.93 billion to $4.04 billion, reflecting a growth of 7.5-10.5%
- Full-year organic revenue growth is expected to be between 7% and 10%
- The management is looking for earnings of $10.84 per share to $11.33 per share for FY24, an increase of 8-13% as reported and on a comparable basis
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Adobe (ADBE) to report Q3 earnings on Sept 12. Here’s what to expect
After delivering record-high revenues in the second quarter, Adobe Inc. (NASDAQ: ADBE) is gearing up to report third-quarter results next week. The design software maker has effectively integrated advanced AI
A look at Campbell Soup’s (CPB) expectations for fiscal year 2025
Shares of Campbell Soup Company (NASDAQ: CPB) rose over 1% on Friday. The stock has gained 21% over the past three months. The company delivered sales and earnings growth for
DOCU Earnings: DocuSign Q2 2025 profit jumps on higher revenues
DocuSign, Inc. (NASDAQ: DOCU) reported a sharp increase in adjusted earnings for the second quarter of 2025. The bottom line benefitted from a 7% increase in revenues. The eSignature service
